Aktie A001060 JW PHARMACEUTICAL CORPORATION
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen JW Pharmaceutical Corporation

Aktien

A001060

KR7001060003

A001060

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 23.05.2024 		% 5 Tage % 1. Jan.
29’500 KRW +0.68% Intraday Chart für JW Pharmaceutical Corporation -2.96% -17.02%
14.03. JW Pharmaceutical Corporation meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
22.01. CJ Logistics sichert sich Distributionsvertrag für intravenöse Lösungen von JW Pharm MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
JW Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CJ Logistics Secures Distribution Deal for JW Pharm's Intravenous Solutions
JW Pharmaceutical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
South Korean Shares Touch Seven-Month Low on Concerns over US Fed Rate Hikes
JW Pharmaceutical Faces Potential Fine of Nearly 30 Billion Won for Alleged Illegal Rebates
El Kospi de Corea cae un 0,6%, su mayor racha de pérdidas desde junio de 2022 -- Market Talk
JW Pharmaceutical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
JW Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
Celleron Therapeutics Ltd acquired Argonaut Therapeutics Limited from JW Pharmaceutical Corporation and Oxford Science Enterprises.
JW Pharmaceutical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
JW Pharmaceutical to Raise $3 Million via Share Sale
JW Pharmaceutical Corporation announced that it expects to receive KRW 9.999993492 billion in funding
JW Pharmaceutical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
JW Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022
JW Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2021
JW Pharmaceutical Corporation announced that it has received KRW 398.470716 million in funding
JW Pharmaceutical Corporation announced that it expects to receive KRW 398.470716 million in funding
JW Pharmaceutical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
JW Pharmaceutical Corporation(KOSE:A001060) dropped from KOSPI 200 Index
JW Pharmaceutical Corporation announced that it has received KRW 300 million in funding
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A001060 Aktie
  4. Nachrichten JW Pharmaceutical Corporation
  5. Andere Sprachen